{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:15:00Z","timestamp":1785838500903,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011733","name":"LPCC","doi-asserted-by":"publisher","award":["LPCC-NRN 2024"],"award-info":[{"award-number":["LPCC-NRN 2024"]}],"id":[{"id":"10.13039\/501100011733","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-breast-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.clbc.2024.11.018","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T08:48:21Z","timestamp":1732697301000},"page":"e331-e340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Is Progesterone Receptor a Neglected Feature in Breast Cancer? A Retrospective Study Analysing the Clinicopathological Characteristics of Breast Cancer Based on Progesterone Receptor Status"],"prefix":"10.1016","volume":"25","author":[{"given":"Ilda","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rute","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deolinda","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00faben","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5292-6337","authenticated-orcid":false,"given":"Carla","family":"Lu\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clbc.2024.11.018_bib0001","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clbc.2024.11.018_bib0002","first-page":"151","article-title":"Epidemiological characteristics of and risk factors for breast cancer in the world","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"9","key":"10.1016\/j.clbc.2024.11.018_bib0003","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/sj.bjc.6602787","article-title":"Clinical characteristics of different histologic types of breast cancer","volume":"93","author":"Li","year":"2005","journal-title":"Br J Cancer"},{"issue":"10286","key":"10.1016\/j.clbc.2024.11.018_bib0004","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.clbc.2024.11.018_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12092440","article-title":"Classical and Non-Classical progesterone signaling in breast cancers","volume":"12","author":"Pedroza","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.clbc.2024.11.018_bib0006","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1524-4741.2009.00822.x","article-title":"Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004","volume":"15","author":"Parise","year":"2009","journal-title":"Breast J"},{"issue":"3","key":"10.1016\/j.clbc.2024.11.018_bib0007","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5306\/wjco.v5.i3.412","article-title":"Biological subtypes of breast cancer: prognostic and therapeutic implications","volume":"5","author":"Yersal","year":"2014","journal-title":"World J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2024.11.018_bib0008","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41523-022-00386-1","article-title":"Immunotherapy for early triple negative breast cancer: research agenda for the next decade","volume":"8","author":"Tarantino","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.clbc.2024.11.018_bib0009","series-title":"Clinical Features, Diagnosis, and Staging of Newly Diagnosed Breast Cancer","author":"HJB","year":"2019"},{"issue":"1-5","key":"10.1016\/j.clbc.2024.11.018_bib0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jsbmb.2007.05.012","article-title":"Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk","volume":"106","author":"Hankinson","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"10.1016\/j.clbc.2024.11.018_bib0011","doi-asserted-by":"crossref","first-page":"T49","DOI":"10.1530\/JME-20-0104","article-title":"90 YEARS OF PROGESTERONE: progesterone and progesterone receptors in breast cancer: past, present, future","volume":"65","author":"Horwitz","year":"2020","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.clbc.2024.11.018_bib0012","series-title":"Physiology, Progesterone","author":"Cable","year":"2024"},{"issue":"Suppl 161","key":"10.1016\/j.clbc.2024.11.018_bib0013","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/aogs.12771","article-title":"Physiology, production and action of progesterone","volume":"94","author":"Taraborrelli","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"10.1016\/j.clbc.2024.11.018_bib0014","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/endrev\/bnz001","article-title":"Progesterone and breast cancer","volume":"41","author":"Trabert","year":"2020","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.clbc.2024.11.018_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamanetworkopen.2020.3645","article-title":"Association of circulating progesterone with breast cancer risk among postmenopausal women","volume":"3","author":"Trabert","year":"2020","journal-title":"Jama Netw Open"},{"key":"10.1016\/j.clbc.2024.11.018_bib0016","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/DDDT.S336643","article-title":"The role of progesterone receptors in breast cancer","volume":"16","author":"Li","year":"2022","journal-title":"Drug Des Devel Ther"},{"issue":"12","key":"10.1016\/j.clbc.2024.11.018_bib0017","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1200\/JCO.18.01967","article-title":"Absolute improvements in freedom from distant recurrence to tailor adjuvant endocrine therapies for premenopausal women: results from TEXT and SOFT","volume":"38","author":"Pagani","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2024.11.018_bib0018","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/bcr1639","article-title":"Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients","volume":"9","author":"Dunnwald","year":"2007","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.clbc.2024.11.018_bib0019","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12957-018-1539-7","article-title":"Characterization and prognosis of estrogen receptor-positive\/progesterone receptor-negative male breast cancer: a population-based study","volume":"16","author":"Wei","year":"2018","journal-title":"World J Surg Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2024.11.018_bib0020","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.3892\/ol.2016.5360","article-title":"Retrospective analysis of breast cancer prognosis among young and older women in a Brazilian cohort of 738 patients, 1985-2002","volume":"12","author":"Vazquez","year":"2016","journal-title":"Oncol Lett"},{"issue":"12","key":"10.1016\/j.clbc.2024.11.018_bib0021","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1093\/ajcn\/32.12.2519","article-title":"Under-appreciated pioneers quetelet - man and index","volume":"32","author":"Jelliffe","year":"1979","journal-title":"Am J Clin Nutr"},{"issue":"8488","key":"10.1016\/j.clbc.2024.11.018_bib0022","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0140-6736(86)91321-8","article-title":"Quetelet index as indicator of obesity","volume":"1","author":"Macdonald","year":"1986","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clbc.2024.11.018_bib0023","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10549-016-3804-1","article-title":"Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer","volume":"157","author":"Green","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2024.11.018_bib0024","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1200\/EDBK_201313","article-title":"New and important changes in the TNM staging system for breast cancer","volume":"38","author":"Hortobagyi","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"4","key":"10.1016\/j.clbc.2024.11.018_bib0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/j.seminoncol.2020.05.010","article-title":"Management of hormone receptor-positive, HER2-negative early breast cancer","volume":"47","author":"Walsh","year":"2020","journal-title":"Semin Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2024.11.018_bib0026","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.maturitas.2012.03.015","article-title":"Systematic review of progesterone use by midlife and menopausal women","volume":"72","author":"Spark","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.clbc.2024.11.018_bib0027","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/CMAR.S144619","article-title":"Association between body mass index and breast cancer risk: evidence based on a dose-response meta-analysis","volume":"10","author":"Liu","year":"2018","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10.1016\/j.clbc.2024.11.018_bib0028","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10549-022-06836-5","article-title":"A retrospective study in tumour characteristics and clinical outcomes of overweight and obese women with breast cancer","volume":"198","author":"Luis","year":"2023","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.clbc.2024.11.018_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-014-3211-4","article-title":"Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesis","volume":"149","author":"Dowsett","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.clbc.2024.11.018_bib0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12282-020-01146-4","article-title":"The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast","volume":"28","author":"Zhao","year":"2021","journal-title":"Breast Cancer"},{"issue":"8","key":"10.1016\/j.clbc.2024.11.018_bib0031","first-page":"1","article-title":"Estrogen and progesterone receptor expression in breast carcinoma and its association with clinicopathological variables among the Pakistani population","volume":"12","author":"Sohail","year":"2020","journal-title":"Cureus J Med Science"},{"issue":"4","key":"10.1016\/j.clbc.2024.11.018_bib0032","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4103\/ijmpo.ijmpo_98_16","article-title":"Correlation of hormone receptor and Human epidermal growth factor receptor-2\/neu expression in breast cancer with various clinicopathologic factors","volume":"38","author":"Bansal","year":"2017","journal-title":"Indian J Med Paediat"},{"issue":"9","key":"10.1016\/j.clbc.2024.11.018_bib0033","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1073\/pnas.95.9.5076","article-title":"A paracrine role for the epithelial progesterone receptor in mammary gland development","volume":"95","author":"Brisken","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.clbc.2024.11.018_bib0034","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1073\/pnas.0510974103","article-title":"Paracrine signaling through the epithelial estrogen receptor \u03b1 is required for proliferation and morphogenesis in the mammary gland","volume":"103","author":"Mallepell","year":"2006","journal-title":"P Natl Acad Sci USA"},{"issue":"18","key":"10.1016\/j.clbc.2024.11.018_bib0035","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1101\/gad.9.18.2266","article-title":"Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities","volume":"9","author":"Lydon","year":"1995","journal-title":"Genes Dev"},{"key":"10.1016\/j.clbc.2024.11.018_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2019.108503","article-title":"Molecular mechanisms underlying progesterone receptor action in breast cancer: insights into cell proliferation and stem cell regulation","volume":"152","author":"Cenciarini","year":"2019","journal-title":"Steroids"},{"issue":"5","key":"10.1016\/j.clbc.2024.11.018_bib0037","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1634\/theoncologist.2017-0535","article-title":"Luminal A breast cancer and molecular assays: a review","volume":"23","author":"Gao","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.clbc.2024.11.018_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111322","article-title":"Mechanisms of endocrine therapy resistance in breast cancer","volume":"532","author":"Rasha","year":"2021","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"10.1016\/j.clbc.2024.11.018_bib0039","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.clbc.2024.11.018_bib0040","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/s41379-019-0270-4","article-title":"Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer","volume":"32","author":"Abubakar","year":"2019","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.clbc.2024.11.018_bib0041","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/epirev\/mxt010","article-title":"Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status","volume":"36","author":"Munsell","year":"2014","journal-title":"Epidemiol Rev"},{"issue":"6","key":"10.1016\/j.clbc.2024.11.018_bib0042","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/bjc.2011.46","article-title":"High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer","volume":"104","author":"Mauland","year":"2011","journal-title":"Brit J Cancer"},{"issue":"3","key":"10.1016\/j.clbc.2024.11.018_bib0043","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10549-010-1116-4","article-title":"Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis","volume":"123","author":"Vrieling","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.clbc.2024.11.018_bib0044","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0959-8049(92)90397-K","article-title":"Relation between steroid-receptor status and body-weight in breast-cancer patients","volume":"28a","author":"Giuffrida","year":"1992","journal-title":"Eur J Cancer"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152682092400332X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152682092400332X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T17:28:21Z","timestamp":1747848501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152682092400332X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S152682092400332X"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2024.11.018","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is Progesterone Receptor a Neglected Feature in Breast Cancer? A Retrospective Study Analysing the Clinicopathological Characteristics of Breast Cancer Based on Progesterone Receptor Status","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2024.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}